Risperidone in the treatment of bipolar mania

Atypical antipsychotic medications have assumed growing importance for the treatment of bipolar disorder, an illness that affects approximately 1.2%–3.7% of the general population in a given year. Current practice guidelines for the treatment of bipolar mania support the use of atypical antipsychoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajatovic, Martha, Subramoniam, Madhusoodanan, Fuller, Matthew A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671778/
https://www.ncbi.nlm.nih.gov/pubmed/19412457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671778/
https://www.ncbi.nlm.nih.gov/pubmed/19412457

Ejemplares similares